Dr. Jessica Spinelli's lab focuses on understanding how a novel metabolite named rhodoquinone (RQ) affects mitochondrial function in the context of obesity. This research investigates how RQ can potentially enhance lipid accumulation and improve energy metabolism in fat cells, which could lead to new treatments for obesity-related diseases. The lab aims to uncover the mechanisms by which RQ influences biological processes and assess its therapeutic potential for metabolic dysfunctions associated with obesity.

Dr. Joel D Richter's lab focuses on understanding how RNA controls neural functions that are essential for learning and memory. They study how errors in RNA translation can lead to disorders like Fragile X Syndrome and autism. The lab combines molecular biology techniques with mouse models to explore how specific proteins regulate the translation and splicing of RNA in the brain, influencing cognitive abilities and behavior.

Dr. Andreas Bergmann's lab at the University of Massachusetts Medical School researches how programmed cell death, or apoptosis, affects tissue health and regeneration. By studying the fruit fly Drosophila, the lab explores how dying cells can signal nearby cells to grow, potentially leading to new cancer treatments. Their work aims to understand the genetic and molecular mechanisms behind these processes, which can enhance our knowledge of diseases like cancer, where cell death and growth signaling are crucial.

Dr. David Guertin's lab focuses on understanding how brown fat helps regulate energy balance and its potential role in fighting obesity-related diseases. By studying how this type of fat metabolizes nutrients, particularly glucose, the lab aims to identify new treatments to promote healthy weight management. The research combines advanced technologies like mass spectrometry and genetics to unravel the complexities of brown fat biology.

Dr. Richard Gregory's lab focuses on understanding the role of RNA modifications in cancer, particularly how these changes can influence gene expression and cancer progression. By studying tRNA and mRNA modifications, the lab aims to uncover novel therapeutic targets for cancer treatment. Their research involves advanced techniques such as RNA mass spectrometry and high-throughput screening to identify potential drugs to combat cancer.

Dr. Kiera L. Clayton's lab at the University of Massachusetts Medical School focuses on understanding how the HIV virus and Mycobacterium tuberculosis (Mtb) evade the immune system, particularly by manipulating natural killer (NK) cells and macrophages. The lab investigates the interactions between these pathogens and immune cells to uncover new mechanisms of immune evasion, aiming to enhance the effectiveness of immune responses and develop new therapeutic strategies.

Dr. Raffi V Aroian's lab focuses on developing new treatments for parasitic nematodes, which are significant contributors to disease and malnutrition globally. The lab uses proteins from the bacterium Bacillus thuringiensis (Bt) that are effective against these parasites, particularly when combined with current anthelmintic drugs. The goal is to find synergistic combinations of these proteins with small-molecule drugs to enhance efficacy and reduce the likelihood of drug resistance.

Dr. Victor Ambros's lab focuses on how genetic networks control when and how an organism develops. They study tiny worms, like C. elegans, to understand the role of microRNAs in helping these organisms adapt to stresses during their growth. Their research also explores how certain worms can regenerate their bodies, offering insights into the biology of regeneration across species.

Dr. Eric Huseby's lab focuses on understanding how genetic variations in immune system genes influence the development and function of T cells involved in type 1 diabetes (T1D). By studying specific mouse models, the lab aims to uncover the processes that lead to autoimmune destruction of insulin-producing cells in the pancreas. This research could help develop better diagnostic tools and therapeutic strategies for T1D and other autoimmune diseases.

Dr. Heinrich Gottlinger's lab at the University of Massachusetts Med School focuses on understanding how a cellular enzyme called ADAM10 interacts with the HIV virus. Their research aims to uncover how ADAM10 influences HIV replication and infection by shedding viral proteins from the surface of the virus. This work could lead to new strategies for targeting HIV and preventing its spread.

Dr. Leslie Shaw's lab focuses on the role of a specific protein, IRS2, in regulating cell division in triple negative breast cancer (TNBC). The lab aims to understand how IRS2 contributes to cancer development and to explore new therapeutic strategies to combat this aggressive cancer subtype by targeting its unique vulnerabilities during cell division. Through their research, they hope to develop more effective treatments for patients with TNBC.

Dr. Amy Karol Walker's lab explores how cellular metabolism influences aging and stress responses. By investigating a specific molecule, S-adenosylmethionine (SAM), the lab aims to understand its role in gene regulation during stress and the aging process. They focus on how different enzymes related to SAM production affect these biological pathways, potentially revealing new insights into aging mechanisms.